Johnson Warns of $400 Million Loss Due to Tariff Policy, Medical Device Division Hit Hardest

On April 15th local time, healthcare giant Johnson & Johnson warned in its financial report that tariffs are expected to result in a $400 million profit loss for the company by 2026, with the medical device division being hit the hardest. "This $400 million loss encompasses several tariff impacts, including import tariffs beyond the scope of the North American Free Trade Agreement from Canada and Mexico, as well as global steel and aluminum tariffs (the latter having a relatively smaller impact). However, tariffs between China and the US undoubtedly account for the largest portion, with products exported from the US to China facing the most significant impact," Volk added.